Translational research center for expedite novel therapies in cystic fibrosis

Active Project Grant Awarded Last action

Award ID
P30DK089507
Recipient
Awarding agency
Obligated
$26,395,605

Award facts

Completion date 82% complete
Originally
Funding
  • $25,180,846.00 Federal
  • $1,214,759.00 Non-federal
Place of performance
Seattle, WA 98105, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment Center for cystic fibrosis translational research in the post-cftr modulator ERA - this P30 cystic fibrosis (CF) research and translational core center… $1,272,697 $0
Amendment Cystic fibrosis translational research in the post-cftr modulator ERA - this P30 cystic fibrosis (CF) research and translational core center (cfrtc) is… $0 $0
Amendment $0 $0
Amendment Center for cystic fibrosis translational research in the post-cftr modulator ERA - this P30 cystic fibrosis (CF) research and translational core center… $0 $0
Amendment $0 $0
Amendment Cystic fibrosis translational research in the post-cftr modulator ERA - this P30 cystic fibrosis (CF) research and translational core center (cfrtc) is… $0 $0
Amendment Center for cystic fibrosis translational research in the post-cftr modulator ERA - this P30 cystic fibrosis (CF) research and translational core center… $1,313,622 $0
Amendment $1,313,622 $0
Amendment $1,313,622 $0
Amendment $1,209,483 $0
Amendment $1,211,277 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,213,036 $0
Amendment $1,213,036 $0
Amendment $1,214,759 $0
Amendment $1,214,759 $1,214,759
Amendment -$339,582 $0
Amendment $339,582 $0
Amendment -$339,582 -$339,582
Amendment $339,582 $339,582
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,230,099 $0
Amendment $1,212,966 $0
Amendment Cystic fibrosis translational research in the post-cftr modulator ERA $0 $0
Amendment $1,212,966 $0
Amendment -$836 $0
Amendment $836 $0
Amendment $1,213,020 $0
Amendment $1,212,966 $0
Amendment $1,225,520 $0
Amendment Translational research center to expedite novel therapies in cystic fibrosis $1,131,845 $0
Amendment $1,068,748 $0
Amendment $1,136,517 $0
Amendment $964,191 $0
Amendment $100,000 $0
Original award $982,095 $0
Show all 40

Subawards

Subrecipient Amount Awarded
Institute For Systems Biology Members of the Venkatesh Lab at ISB will be responsible for the execution of experiments to serve the scientific aims of the proposed research in the pilot… $141,000
University Of Washington The P30 Cystic Fibrosis (CF) Research and Translational Core Center (CFRTC) at the University of Washington School of Medicine (UWSOM) will work to enhance… $933,914
Institute For Systems Biology Members of the Venkatesh Lab at ISB will be responsible for the execution of experiments to serve the scientific aims of the proposed research in the pilot… $141,000
University Of Washington The P30 Cystic Fibrosis (CF) Research and Translational Core Center (CFRTC) at the University of Washington School of Medicine (UWSOM) will work to enhance… $1,009,528
Fred Hutchinson Cancer Center Dr. William M. Grady, M. D., is a co- Principal Investigator. In this project, Dr. Grady will serve as a PI of this this collaborative study on understanding of… $215,351
University Of Washington The P30 Cystic Fibrosis (CF) Research and Translational Core Center (CFRTC) at the University of Washington School of Medicine (UWSOM) will work to enhance… $1,135,861

Quick answers

Who received award P30DK089507?

P30DK089507 was awarded to Seattle Children's Hospital by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on July 6, 2010.

How much is award P30DK089507 worth?

$26,395,605 has been obligated on P30DK089507: $25,180,846 in federal funding and $1,214,759 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login